A European perspective on the management of donors and units testing positive for hepatitis B virus DNA

被引：18

作者：

Allain, JP ^{[1
]}

Reesink, HW

Lucey, C

机构：

[1] Univ Cambridge, Cambridge CB2 1TN, England

[2] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands

[3] Sanquin Blood Supply Fdn, Dept Gastroenterol & Hepatol, Amsterdam, Netherlands

[4] 21st Century Hlth Concepts Assoc, Houston, TX USA

来源：

TRANSFUSION | 2006年 / 46卷 / 07期

关键词：

D O I：

10.1111/j.1537-2995.2006.00885.x

中图分类号：

R5 [内科学];

学科分类号：

100201 [内科学];

摘要：

引用

页码：1256 / 1258

页数：3

共 6 条

[1]

Occult hepatitis B virus infection: implications in transfusion [J].

Allain, JP .

VOX SANGUINIS, 2004, 86 (02) :83-91

[2]

*BLOOD PROD ADV CO, 2005, TOP 1 FDA CURR CONS

[3]

Intermittent HBV viraemia in an anti-HBc- and anti-HBs-positive blood donor -: Reply [J].

Dreier, J ;

Kröger, M ;

Diekmann, J ;

Götting, C ;

Kleesiek, K .

TRANSFUSION MEDICINE, 2005, 15 (01) :65-66

[4]

*FDA CTR BIOL EV R, 83 M BLOOD PROD ADV

[5]

Genetic variability in hepatitis B viruses [J].

Kidd-Ljunggren, K ;

Miyakawa, Y ;

Kidd, AH .

JOURNAL OF GENERAL VIROLOGY, 2002, 83 :1267-1280

[6]

*UK BLOOD TRANSF S, 2005, GUID BLOOD TRANSF SE

← 1 →